findmyKOL
Clinical trialNCT00735917CompletedPhase 2Interventional

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

SponsorNational Cancer Institute (NCI)Enrollment19Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia

Singapore
  • National University Hospital

    Singapore, Singapore

United States
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

  • University of Colorado at Denver

    Aurora, Colorado, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • Wayne State University/karmanos Cancer Institute

    Detroit, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2008
Primary completion
30 Apr 2011
Completion
31 Oct 2012
Last update posted
2 Apr 2019
Registered enrollment
19
Registry id
NCT00735917

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.